Evariant, which offers an end-to-end CRM solution, has announced it received $42.3M in Series C financing through financial institution, Goldman Sachs, which will be used toward innovations in their current CRM healthcare platform for providers.
The company also said it secured both Series A and B leads in Health Enterprise Partners and Lightspeed Venture Partners, who have raised additional funding on behalf of the brand.
With over $70M in funding, the startup plans to focus on growth and evolution of their platform, starting with service lines, engineering and customer success teams. Recently opening a fourth office in Austin, this capital will allow Evariant to expand opportunities and support directly to nearby healthcare providers.
“It is no secret that healthcare systems are facing a variety of complex market challenges. These issues are not going to be solved by a collection of point solutions, but rather by an integrated platform that can scale and address the healthcare markets’ analytics and CRM needs of today and tomorrow,” stated Evariant Chief Executive Officer, William Moschella. “Our advances with big data and streaming analytics will yield significant market advantages to our customers. We are excited to leverage this additional investment to address core and new healthcare system requirements.”
Evariant’s ultimate goal is to be a solution providing healthcare organizations with precise delivery of efficient care solutions both inside and outside of the organization’s walls. The company connects patients with healthcare providers specializing in specific care needs, instituting value-based healthcare delivery models in playing a better role in the matchmaking process. This not only reduces the overall costs to operation for associated healthcare systems, but it also serves the patient experience with better results. Healthcare systems are attracted to the ease-of-use and analytics systems that help them to better understand the needs of patients and provider tenets.
“With over 600 hospitals and six out of the top 10 health systems as customers, Evariant has clearly demonstrated to the healthcare provider market that they are the leaders and innovators to watch,” states Jason Kreuziger, a Vice President in the Merchant Banking Division of Goldman Sachs. “The company,” he continues, “has transformed many classic marketing and business development models by providing superior software products and customer experiences, leveraging sophisticated big data technology. We aim to invest in companies that are market leaders and solve major healthcare pain points by rethinking a traditional approach.”
Evariant’s CRM platform centralizes healthcare data into a localized hub and gathers that data to deliver analytics to healthcare service providers for application in reaching organizational goals and patient success. This platform identifies opportunities, measuring engagement potential and assisting in better execution of engagement initiatives. This data will also be at the forefront of the innovation project, improving the platform for future adoption by healthcare providers in providing better relations and management with patients in need. Evariant was recently ranked as the 272nd “fasted growing company in North America,” as named by Deloitte’s 2015 Technology Fast 500.
Edited by Stefania Viscusi